China Resources Double Crane (600062.SH) subsidiary Qinhuangdao Purple Bamboo Pharmaceutical Co., Ltd. passes GMP compliance inspection.

Wisdom Financial News APP, China Resources Shuanghe (600062.SH) announced that its wholly-owned subsidiary Qinhuangdao Purple Bamboo Pharmaceutical Co., Ltd. (referred to as "Qinhuangdao Purple Bamboo") recently received the "Drug GMP Compliance Inspection Notice" of estrogen active pharmaceutical ingredient issued by the Hebei Provincial Drug Administration [Number: Ji Yao Jian Hua Yao Fu (2025) No. 151]. The inspection scope includes related workshops and production lines of the active pharmaceutical ingredient (estrogen, multi-functional workshop production line 10).